VIVORYON THERAPEUTICS NV (VVY.AS) Stock Analyst Ratings
Europe - Euronext Amsterdam - AMS:VVY - NL00150002Q7 - Common Stock
1.618 EUR
+0.01 (+0.75%)
ChartMill assigns a Buy % Consensus number of 86% to VVY.AS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.23. This target is 223.08% above the current price.
VVY.AS was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VVY.AS.
In the previous month the buy percentage consensus was at a similar level.
VVY.AS was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-06 | HAUCK AUFHAEUSER INVESTMENT BANKING | Maintains | Buy -> Buy |
VIVORYON THERAPEUTICS NV / VVY.AS FAQ
What is the average price target for VIVORYON THERAPEUTICS NV (VVY.AS) stock?
7 analysts have analysed VVY.AS and the average price target is 5.23 EUR. This implies a price increase of 223.08% is expected in the next year compared to the current price of 1.618.
Can you provide the consensus rating for VIVORYON THERAPEUTICS NV stock?
The consensus rating for VIVORYON THERAPEUTICS NV (VVY.AS) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for VVY stock?
The number of analysts covering VIVORYON THERAPEUTICS NV (VVY.AS) is 7.